Please ensure Javascript is enabled for purposes of website accessibility

Why Vericel Stock Raced 13% Higher on Thursday

By Eric Volkman - Updated Mar 18, 2021 at 6:15PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company will be a component of a well-known small-cap stock index.

What happened

Vericel (VCEL -1.01%) was a big hit on an otherwise forgettable Thursday for the stock market, closing the day up more than 13%. This followed the news that the company has been tipped for inclusion in an important stock index.

So what

Late Wednesday, S&P Dow Jones Indices announced that Vericel is to become a component of its S&P SmallCap 600 index. It replaces energy company QEP Resources, which is being acquired by Diamondback Energy. The switch takes effect before market open on Monday, March 22.

Athlete stretching on a track.

Vericel, whose MACI treats cartilage defects in the knee, is joining an important stock index. Image source: Getty Images.

While inclusion on a relatively high-profile index is certainly an achievement, it's important to remember that it barely affects the fundamentals of a company, if at all. It does increase its prominence among investors and makes it a target of the armies of index funds that trawl such listings for their portfolios. But in the end, research indicates that the "index effect" is short-lived at best.

On top of that, Vericel became relatively widely known among the investing community on the back of very optimistic guidance for 2021 and the success of its distinctive MACI, a drug that treats cartilage defects in the knee. As such, its share price has risen more than sixfold over the past year.

Now what

That said, Vericel remains a healthcare company to watch. Its work is based on cell therapy, a promising area of care in which whole cells are transplanted into patients to help them heal from a variety of afflictions. We'll certainly hear more from Vericel in the coming months and years.

 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Vericel Corporation Stock Quote
Vericel Corporation
VCEL
$25.38 (-1.01%) $0.26
Diamondback Energy, Inc. Stock Quote
Diamondback Energy, Inc.
FANG
$130.60 (4.99%) $6.21
QEP Resources, Inc. Stock Quote
QEP Resources, Inc.
QEP

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
332%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.